Cargando…

Erratum to: CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease

Detalles Bibliográficos
Autores principales:	Pawlak-Adamska, Edyta, Frydecka, Irena, Bolanowski, Marek, Tomkiewicz, Anna, Jonkisz, Anna, Karabon, Lidia, Partyka, Anna, Nowak, Oskar, Szalinski, Marek, Daroszewski, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483889/ https://www.ncbi.nlm.nih.gov/pubmed/28243970 http://dx.doi.org/10.1007/s12020-017-1259-8

Ejemplares similares

CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves’ disease and modulates clinical phenotype of disease
por: Pawlak-Adamska, Edyta, et al.
Publicado: (2016)

Variations in Suppressor Molecule CTLA-4 Gene Are Related to Susceptibility to Multiple Myeloma in a Polish Population
por: Karabon, Lidia, et al.
Publicado: (2011)

A CT60G>A polymorphism in the CTLA-4 gene of the recipient may confer susceptibility to acute graft versus host disease after allogeneic hematopoietic stem cell transplantation
por: Karabon, Lidia, et al.
Publicado: (2015)

Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia
por: Frydecka, Dorota, et al.
Publicado: (2013)

Gene Polymorphisms of Novel Immunotolerant Molecule BTLA: Distribution of Alleles, Genotypes and Haplotypes in Polish Caucasian Population
por: Partyka, Anna, et al.
Publicado: (2014)

Abnormal Expression of BTLA and CTLA-4 Immune Checkpoint Molecules in Chronic Lymphocytic Leukemia Patients
por: Karabon, L., et al.
Publicado: (2020)

Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia
por: Karabon, Lidia, et al.
Publicado: (2016)

The Influence of Genetic Variations in the CD86 Gene on the Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
por: Karabon, Lidia, et al.
Publicado: (2018)

Interleukin-6: the missing element of the neurocognitive deterioration in schizophrenia? The focus on genetic underpinnings, cognitive impairment and clinical manifestation
por: Frydecka, Dorota, et al.
Publicado: (2014)

Sex differences in TGFB-β signaling with respect to age of onset and cognitive functioning in schizophrenia
por: Frydecka, Dorota, et al.
Publicado: (2015)

Variation in the gene encoding the co-inhibitory molecule BTLA is associated with survival in patients treated for clear cell renal carcinoma – results of a prospective cohort study
por: Tupikowski, Krzysztof, et al.
Publicado: (2021)

Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors
por: Kulikowska de Nałęcz, Anna, et al.
Publicado: (2023)

Polymorphisms of genes encoding cytokines predict the risk of high-grade bladder cancer and outcomes of BCG immunotherapy
por: KRAJEWSKI, WOJCIECH, et al.
Publicado: (2020)

Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement
por: Kosmaczewska, Agata, et al.
Publicado: (2013)

Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
por: Fan, Xiaozhou, et al.
Publicado: (2014)

Patients with chronic lymphocytic leukaemia (CLL) differ in the pattern of CTLA-4 expression on CLL cells: the possible implications for immunotherapy with CTLA-4 blocking antibody
por: Ciszak, Lidia, et al.
Publicado: (2015)

Association of the CTLA4 Gene with Graves' Disease in the Chinese Han Population
por: Zhao, Shuang-Xia, et al.
Publicado: (2010)

Correlation of TSHR and CTLA-4 Single Nucleotide Polymorphisms with Graves Disease
por: Sun, Weihua, et al.
Publicado: (2019)

Polymorphisms in the CD28/CTLA4/ICOS genes: role in malignant melanoma susceptibility and prognosis?
por: Bouwhuis, Marna G., et al.
Publicado: (2009)

S35. Investigating the ICOS/ICOSL pathway as a target for combination therapy with anti-CTLA-4
por: Sharma, P
Publicado: (2014)

Dysregulated Expression of Both the Costimulatory CD28 and Inhibitory CTLA-4 Molecules in PB T Cells of Advanced Cervical Cancer Patients Suggests Systemic Immunosuppression Related to Disease Progression
por: Kosmaczewska, Agata, et al.
Publicado: (2011)

ICOS Regulates the Generation and Function of Human CD4(+) Treg in a CTLA-4 Dependent Manner
por: Zheng, Jian, et al.
Publicado: (2013)

ICOS Costimulation at the Tumor Site in Combination with CTLA-4 Blockade Therapy Elicits Strong Tumor Immunity
por: Soldevilla, Mario Martínez, et al.
Publicado: (2019)

Medical treatment of Cushing’s disease with concurrent diabetes mellitus
por: Mehlich, Anna, et al.
Publicado: (2023)

Actual Associations between HLA Haplotype and Graves’ Disease Development
por: Zawadzka-Starczewska, Katarzyna, et al.
Publicado: (2022)

The associations between the polymorphisms in the CTLA-4 gene and the risk of Graves’ disease in the Chinese population
por: Du, Liang, et al.
Publicado: (2013)

Haplotype-defined linkage region for gPRA in Schapendoes dogs
por: Lippmann, Tanja, et al.
Publicado: (2007)

CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves’ disease and Hashimoto's thyroiditis)
por: Pastuszak-Lewandoska, Dorota, et al.
Publicado: (2012)

Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients
por: Kulikowska de Nałęcz, Anna, et al.
Publicado: (2021)

Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4
por: Botturi, Karine, et al.
Publicado: (2011)

Specific Alteration of Branched-Chain Amino Acid Profile in Polycystic Ovary Syndrome
por: Paczkowska, Katarzyna, et al.
Publicado: (2023)

Alteration of Branched-Chain and Aromatic Amino Acid Profile as a Novel Approach in Studying Polycystic Ovary Syndrome Pathogenesis
por: Paczkowska, Katarzyna, et al.
Publicado: (2023)

ICO investors
por: Fahlenbrach, Rüdiger, et al.
Publicado: (2020)

The association of BTLA gene polymorphisms with non-small lung cancer risk in smokers and never-smokers
por: Andrzejczak, Anna, et al.
Publicado: (2023)

Selective Laser Trabeculoplasty in the Treatment of Ocular Hypertension and Open-Angle Glaucoma: Clinical Review
por: Zgryźniak, Aleksandra, et al.
Publicado: (2021)

Association between the CTLA-4 +49A/G polymorphism and Graves’ disease: A meta-analysis
por: SI, XIAOYU, et al.
Publicado: (2012)

Meta-analysis of the rs231775 locus polymorphism in the CTLA-4 gene and the susceptibility to Graves’ disease in children
por: Shi, Mili, et al.
Publicado: (2023)

Investigation of the Correlation between Graves’ Ophthalmopathy and CTLA4 Gene Polymorphism
por: Chen, Ding-Ping, et al.
Publicado: (2019)

Validation of exophthalmos magnetic resonance imaging measurements in patients with Graves’ orbitopathy, compared to ophthalmometry results
por: Wnuk, Emilia, et al.
Publicado: (2022)

CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia
por: Ciszak, Lidia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_i4klqfgnqvtolah85e10513pgr